search
Company Information
USD
47.01
- (1.1%)
NASDAQ:TWST, TWIST BIOSCIENCE CORPORATION
Industry: Diagnostics & Research
End of Day: 17 May 2024 GMT-4
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.

Address

681 Gateway Boulevard

Classification

Sector

Healthcare

Industry Group

Medical Diagnostics & Research

Industry

Diagnostics & Research

Key Executives

Mr. Adam Laponis
CFO
Mr. Keith L. Crandell
Director
Mr. Nelson C. Chan
Director
Mr. Robert B. Chess
Director
Mr. Jan Johannessen
Director
Dr. William Banyai, PhD
Co-Founder/Director/General Manager, Divisional/Senior VP, Divisional
Mr. Robert Ragusa
Director
Mr. Robert F. Werner
Chief Accounting Officer
Dr. Emily M. Leproust, PhD
CEO/Chairman of the Board/Co-Founder/Director
Ms. Paula Green
Senior VP, Divisional
Dr. Patrick Finn, PhD
COO/President
Ms. Xiaoying Mai
Director
Dr. Melissa Starovasnik, PhD
Director
Mr. Dennis Cho
Chief Compliance Officer/General Counsel/Other Executive Officer/Secretary/Senior VP

Ownership

Institution Holdings

ARK Investment Management LLC
7,213,257 (12.476%)
BlackRock Inc
5,947,453 (10.287%)
Vanguard Group Inc
5,475,322 (9.470%)
JPMorgan Chase & Co
4,616,073 (7.984%)
Artisan Partners Limited Partnership
3,723,305 (6.440%)
Nikko Asset Management Americas Inc
3,583,443 (6.198%)
Sumitomo Mitsui Trust Holdings Inc
3,583,443 (6.198%)
William Blair Investment Management, LLC
3,549,874 (6.140%)
State Street Corporation
3,362,215 (5.815%)
FMR LLC
3,087,060 (5.339%)

Individual Holdings

Dr. Emily M. Leproust, PhD
516,605 (0.894%)
Dr. William Banyai, PhD
347,304 (0.601%)
Dr. Patrick Finn, PhD
178,140 (0.308%)
Ms. Paula Green
92,689 (0.160%)
Mr. Dennis Cho
80,437 (0.139%)
Mr. Adam Laponis
75,000 (0.130%)
Mr. Robert B. Chess
64,169 (0.111%)
Mr. Robert F. Werner
43,861 (0.076%)
Ms. Xiaoying Mai
31,057 (0.054%)
Mr. Nelson C. Chan
23,684 (0.041%)

Funds Holdings

ARK Disruptive Innovation Full Composite
3,742,852 (6.474%)
ARK Innovation ETF
3,499,352 (6.052%)
ARK Genomic Revolution
3,109,319 (5.378%)
ARK Genomic Revolution ETF
2,839,518 (4.911%)
SPDR® S&P Biotech ETF
2,156,028 (3.729%)
Vanguard Total Stock Market Index Fund
1,723,306 (2.981%)
Vanguard US Total Market Shares ETF
1,723,306 (2.981%)
Vanguard Small Cap Index
1,399,175 (2.420%)
iShares Russell 2000 ETF
1,392,250 (2.408%)
Artisan Small Cap Fund
938,288 (1.623%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices